TNF Pharmaceuticals, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q3 2016 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
TNF Pharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q3 2016 to Q1 2024.
  • TNF Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2024 was $299K, a 1401% increase year-over-year.
  • TNF Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $1.96M, a 479% increase from 2022.
  • TNF Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $339K, a 277% increase from 2021.
  • TNF Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $90K.
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $299K +$279K +1401% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q1 2023 $19.9K -$61.1K -75.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q1 2022 $81K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q3 2016 $38.3K Jul 1, 2016 Sep 30, 2016 10-Q 2016-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.